|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases metabolic processing increases expression |
ISO |
1-aminobenzotriazole inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; [CYP1A1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine; Cycloheximide promotes the reaction [Skatole results in increased expression of CYP1A1 mRNA]; CYP1A1 protein results in increased metabolism of and results in increased activity of Skatole; Dactinomycin inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; Skatole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Skatole metabolite results in increased expression of CYP1A1 mRNA; Skatole results in increased expression of CYP1A1 mRNA; Skatole results in increased expression of CYP1A1 protein |
CTD |
PMID:20187624 PMID:20795680 PMID:28571685 PMID:31201936 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
Skatole results in increased expression of CYP1A2 mRNA; Skatole results in increased expression of CYP1A2 protein |
CTD |
PMID:28571685 PMID:31201936 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
Skatole results in increased expression of CYP1B1 mRNA |
CTD |
PMID:28571685 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
multiple interactions increases metabolic processing |
ISO |
[CYP2A13 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine; [Methoxsalen results in decreased activity of CYP2A13 protein] which results in decreased susceptibility to Skatole; CYP2A13 protein results in increased metabolism of and results in increased activity of Skatole |
CTD |
PMID:20187624 PMID:20795680 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
Skatole results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:28571685 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
increases expression increases metabolic processing multiple interactions |
ISO |
Skatole metabolite results in increased expression of CYP2F1 mRNA CYP2F1 protein results in increased metabolism of Skatole 1-aminobenzotriazole inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA]; [CYP2F1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine; Cycloheximide inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA]; CYP2F1 protein results in increased metabolism of and results in increased activity of Skatole; Dactinomycin inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 PMID:20795680 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions decreases expression |
ISO |
Skatole inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Skatole inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein] Skatole results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:28571685 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
multiple interactions increases metabolic processing |
ISO |
[CYP4B1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine |
CTD |
PMID:20187624 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
decreases expression increases expression |
ISO |
Skatole results in decreased expression of NR1I2 mRNA Skatole results in increased expression of NR1I2 mRNA |
CTD |
PMID:28571685 PMID:32092453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Skatole results in increased cleavage of PARP1 protein |
CTD |
PMID:19700606 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
Skatole results in increased phosphorylation of and affects the localization of TP53 protein |
CTD |
PMID:19700606 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|